On March 7, 2018 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported that Kevin Gorman, CEO of Neurocrine Biosciences, will present at the following investor conferences (Press release, Neurocrine Biosciences, MAR 7, 2018, View Source;p=RssLanding&cat=news&id=2336833 [SID1234524512]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 38th Annual Health Care Conference at 10:00 a.m. ET on Wednesday, March 14, 2018, in Boston.
Barclays Global Healthcare Conference at 1:35 p.m. ET on Thursday, March 15, 2018, in Miami.
Oppenheimer 28th Annual Healthcare Conference at 10:55 a.m. ET on Wednesday, March 21, 2018, in New York City.
The live presentations will be webcast and may be accessed on the Company’s website under Investors at View Source A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.